Novo Nordisk

Art directed a generative AI concept for a Novo Nordisk pitch centered on FGF21, an emerging therapy with multi-domain efficacy across MASH fibrosis.

The visual narrative reframes years of scientific groundwork as a crowded, time-worn archive — and FGF21 as the force that finally opens the door, turning accumulated evidence into clinical momentum.